⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL72995 | 0.96 | — | — | |
| SCHEMBL8331427 | 0.78 | — | — | |
| SCHEMBL24525843 | 0.75 | CYP2D6 (0.30) | — | |
| Hydrochloric Acid SCHEMBL5255990 | 0.75 | — | — | |
| SCHEMBL21794057 | 0.72 | — | — | |
| SCHEMBL11787115 | 0.72 | — | — | |
| SCHEMBL1040252 | 0.70 | — | — | |
| SCHEMBL14667932 | 0.70 | — | — | |
| SCHEMBL5443031 | 0.70 | GRM4 (0.41) | — | |
| SCHEMBL14420440 | 0.70 | GRM4 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230033510-A1 | Compounds and Methods for Treatment of Visceral Pain | ARENA PHARMACEUTICALS, INC. | 2023-02-02 | — | — | US | claimed |
| EP-3385252-B1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARM INC (US) | 2022-09-21 | — | — | EP | claimed |
| US-20210060040-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2021-03-04 | — | — | US | claimed |
| US-10632134-B2 | Cannabinoid receptor modulators | ARENA PHARMACEUTICALS, INC. (US) | 2020-04-28 | — | — | US | claimed |
| US-20200078358-A1 | Compounds and Methods for Treatment of Visceral Pain | ARENA PHARMACEUTICALS, INC. | 2020-03-12 | — | — | US | claimed |
| CN-110709085-A | Compounds and methods for treating visceral pain | 艾尼纳制药公司 | 2020-01-17 | — | — | CN | claimed |
| US-20180354907-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2018-12-13 | — | — | US | claimed |
| EP-3385252-A1 | CANNABINOID RECEPTOR MODULATORS | Arena Pharmaceuticals, Inc. (US) | 2018-10-10 | — | — | EP | claimed |
| EP-3363788-A1 | CANNABINOID RECEPTOR MODULATORS | Arena Pharmaceuticals, Inc. (US) | 2018-08-22 | — | — | EP | claimed |
| US-20170304327-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2017-10-26 | — | — | US | claimed |
| US-9597340-B2 | Cannabinoid receptor modulators | ARENA PHARMACEUTICALS, INC. (US) | 2017-03-21 | — | — | US | claimed |
| US-9492447-B2 | Cannabinoid receptor modulators | ARENA PHARMACEUTICALS, INC. (US) | 2016-11-15 | — | — | US | claimed |
| US-20160271127-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2016-09-22 | — | — | US | claimed |
| US-20150126477-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2015-05-07 | — | — | US | claimed |
| US-20140206649-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2014-07-24 | — | — | US | claimed |
| WO-2012116277-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. (US) | 2012-08-30 | — | — | WO | claimed |
| US-20120214766-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2012-08-23 | — | — | US | claimed |
| EP-0240818-B1 | FLUORINATED TERTIARY BUTYL AMINES | BAYER AG (DE) | 1991-12-04 | — | — | EP | claimed |
| US-5019654-A | Fluorinated tertiary butylamines | BAYER AKTIENGESELLSCHAFT (DE) | 1991-05-28 | — | — | US | claimed |
| EP-0240818-A1 | Fluorinated tertiary butyl amines | BAYER AG (DE) | 1987-10-14 | — | — | EP | claimed |